Stephen Gucker

Array ( [id] => 1403785 [patent_doc_number] => 06534479 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Recombinant alpha-fetoprotein hybrid cytotoxins for treating and diagnosing cancers' [patent_app_type] => B1 [patent_app_number] => 08/758757 [patent_app_country] => US [patent_app_date] => 1996-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12614 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534479.pdf [firstpage_image] =>[orig_patent_app_number] => 08758757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939663 [patent_doc_number] => 05989834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Uses of nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors nucleic acid encoding' [patent_app_type] => 1 [patent_app_number] => 8/687355 [patent_app_country] => US [patent_app_date] => 1996-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 48 [patent_no_of_words] => 35728 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989834.pdf [firstpage_image] =>[orig_patent_app_number] => 687355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528294 [patent_doc_number] => 06479459 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Cytokine designated lerk-5' [patent_app_type] => B1 [patent_app_number] => 08/739333 [patent_app_country] => US [patent_app_date] => 1996-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13983 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479459.pdf [firstpage_image] =>[orig_patent_app_number] => 08739333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725487 [patent_doc_number] => 20030207799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'GLIAL MITOGENIC FACTORS, THEIR PREPARATION AND USE' [patent_app_type] => new [patent_app_number] => 08/736019 [patent_app_country] => US [patent_app_date] => 1996-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 27798 [patent_no_of_claims] => 131 [patent_no_of_ind_claims] => 70 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207799.pdf [firstpage_image] =>[orig_patent_app_number] => 08736019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923047 [patent_doc_number] => 07319019 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-01-15 [patent_title] => 'Glial mitogenic factors lacking an N-terminal signal sequence' [patent_app_type] => utility [patent_app_number] => 08/734665 [patent_app_country] => US [patent_app_date] => 1996-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 89 [patent_no_of_words] => 28544 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319019.pdf [firstpage_image] =>[orig_patent_app_number] => 08734665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260093 [patent_doc_number] => 06204241 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Method for treating nervous system pathophysiologies using glial growth factors' [patent_app_type] => 1 [patent_app_number] => 8/734664 [patent_app_country] => US [patent_app_date] => 1996-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 81 [patent_figures_cnt] => 90 [patent_no_of_words] => 28764 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204241.pdf [firstpage_image] =>[orig_patent_app_number] => 734664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 515538 [patent_doc_number] => 07192915 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-20 [patent_title] => 'Methods for treating multiple sclerosis with GGF-related polypeptides' [patent_app_type] => utility [patent_app_number] => 08/735010 [patent_app_country] => US [patent_app_date] => 1996-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 89 [patent_no_of_words] => 28097 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192915.pdf [firstpage_image] =>[orig_patent_app_number] => 08735010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668508 [patent_doc_number] => 07094749 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => 'Glial mitogenic factors, their preparation and use' [patent_app_type] => utility [patent_app_number] => 08/734592 [patent_app_country] => US [patent_app_date] => 1996-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 88 [patent_no_of_words] => 28186 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094749.pdf [firstpage_image] =>[orig_patent_app_number] => 08734592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418246 [patent_doc_number] => 06194377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Methods for treating nervous system pathophysiologies using glial growth factors' [patent_app_type] => 1 [patent_app_number] => 8/735021 [patent_app_country] => US [patent_app_date] => 1996-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 91 [patent_no_of_words] => 28363 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194377.pdf [firstpage_image] =>[orig_patent_app_number] => 735021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4200807 [patent_doc_number] => 06013767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Brain-specific adapter molecule, gene thereof, and antibody thereto' [patent_app_type] => 1 [patent_app_number] => 8/729416 [patent_app_country] => US [patent_app_date] => 1996-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 16 [patent_no_of_words] => 16986 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013767.pdf [firstpage_image] =>[orig_patent_app_number] => 729416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089741 [patent_doc_number] => 06096302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Assay for the measurement of neuronal degradation and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/725876 [patent_app_country] => US [patent_app_date] => 1996-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6283 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096302.pdf [firstpage_image] =>[orig_patent_app_number] => 725876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098934 [patent_doc_number] => 06066469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Cloning, expression, and uses of human lactoferrin' [patent_app_type] => 1 [patent_app_number] => 8/724586 [patent_app_country] => US [patent_app_date] => 1996-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12140 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066469.pdf [firstpage_image] =>[orig_patent_app_number] => 724586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1377353 [patent_doc_number] => 06555337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-29 [patent_title] => 'Neurogenin' [patent_app_type] => B2 [patent_app_number] => 08/722570 [patent_app_country] => US [patent_app_date] => 1996-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13089 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555337.pdf [firstpage_image] =>[orig_patent_app_number] => 08722570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4319078 [patent_doc_number] => 06331304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor' [patent_app_type] => 1 [patent_app_number] => 8/713768 [patent_app_country] => US [patent_app_date] => 1996-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 4393 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331304.pdf [firstpage_image] =>[orig_patent_app_number] => 713768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346942 [patent_doc_number] => 06214615 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Cloned genes for human dopamine D2 receptors and cell lines expressing same' [patent_app_type] => 1 [patent_app_number] => 8/709298 [patent_app_country] => US [patent_app_date] => 1996-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 10935 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214615.pdf [firstpage_image] =>[orig_patent_app_number] => 709298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357134 [patent_doc_number] => 06569432 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Prostate-specific membrane antigen and uses thereof' [patent_app_type] => B1 [patent_app_number] => 08/705477 [patent_app_country] => US [patent_app_date] => 1996-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 106 [patent_no_of_words] => 37292 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569432.pdf [firstpage_image] =>[orig_patent_app_number] => 08705477 [rel_patent_id] =>[rel_patent_doc_number] =>)